Portfolio company
Ad Scientiam
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops smartphone-based medical software and digital biomarkers for patients and clinicians to monitor the progression of serious, disabling or rare diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DEEP Measures
This company provides a platform for developing and validating digital biomarkers and endpoints for pharmaceutical companies and clinical research organisations.
HOME REPORTED OUTCOMES
This company provides a mobile platform for patients and caregivers to track health data for clinical research and personalised care.
Elsa Science
This company provides a digital health platform and mobile application for patients with rheumatic diseases to track symptoms and manage their treatment.
Koios Care
This digital medicine company develops an AI platform that monitors Parkinson’s disease symptoms using wearable devices for healthcare providers and pharmaceutical researchers.
ActualSignal
ActualSignal develops a smartphone-based remote monitoring platform for Parkinson's disease patients to provide longitudinal clinical insights for neurology clinics and healthcare organisations.
Sanius Health
This company provides a health data platform and wearable devices for patients with rare diseases and researchers to monitor symptoms and accelerate drug discovery.
Tilak Healthcare
This company develops a mobile application for patients with chronic eye diseases to monitor their vision through gamified tests for ophthalmologists.
BeCareLink
This company develops mobile applications using artificial intelligence to monitor and assess neurological functions for patients and healthcare providers.
